Q11681 (Q11681): Difference between revisions
Jump to navigation
Jump to search
(Removed claims) |
(Changed an Item) |
||||||||||||||
| Property / EU contribution | |||||||||||||||
7,740,698.73 Czech koruna
| |||||||||||||||
| Property / EU contribution: 7,740,698.73 Czech koruna / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / EU contribution | |||||||||||||||
309,627.94920000003 Euro
| |||||||||||||||
| Property / EU contribution: 309,627.94920000003 Euro / rank | |||||||||||||||
Preferred rank | |||||||||||||||
| Property / EU contribution: 309,627.94920000003 Euro / qualifier | |||||||||||||||
exchange rate to Euro: 0.04 Euro
| |||||||||||||||
| Property / EU contribution: 309,627.94920000003 Euro / qualifier | |||||||||||||||
point in time: 10 January 2020
| |||||||||||||||
| Property / budget | |||||||||||||||
11,073,961.0 Czech koruna
| |||||||||||||||
| Property / budget: 11,073,961.0 Czech koruna / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / budget | |||||||||||||||
442,958.44 Euro
| |||||||||||||||
| Property / budget: 442,958.44 Euro / rank | |||||||||||||||
Preferred rank | |||||||||||||||
| Property / budget: 442,958.44 Euro / qualifier | |||||||||||||||
exchange rate to Euro: 0.04 Euro
| |||||||||||||||
| Property / budget: 442,958.44 Euro / qualifier | |||||||||||||||
point in time: 10 January 2020
| |||||||||||||||
Revision as of 01:35, 12 February 2020
Project in Czech Republic financed by DG Regio
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | No label defined |
Project in Czech Republic financed by DG Regio |
Statements
7,740,698.73 Czech koruna
0 references
11,073,961.0 Czech koruna
0 references
69.8999999187283 percent
0 references
31 October 2020
0 references
ESSENCE LINE, s.r.o.
0 references
50°4'11.50"N, 14°22'51.56"E
0 references
50°4'6.46"N, 14°23'8.41"E
0 references
15000
0 references
15000
0 references
Cílem projektu je vyvinout nový DNA-biochip pro racionalizovanou preskripci psychofarmak pro pacienty s psychiatrickým onemocněním a tím přinést prospěch nejen pacientovi, ale snížit náklady zdravotních pojišťoven. Přínosem projektu bude bezpečnější a efektivnější preskripce psychofarmak, což povede k úspěšnější farmakoterapii, zvýší komfort pacienta v podobě pozitivní terapie a sníží náklady na neefektivně aplikovaná psychofarmaka a negativní dopady na pacienta. a. (Czech)
0 references
Identifiers
CZ.01.1.02/0.0/0.0/17_107/0012433
0 references